Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    aTyr Pharma Inc.

    NASDAQ: LIFE · Real-Time Price · USD
    1.90
    0.05 (2.70%)
    At close: Jun 04, 2024, 10:00 PM

    aTyr Pharma Statistics

    Share Statistics

    aTyr Pharma has 69.01M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 69.01M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 67.12M

    Failed to Deliver (FTD) Shares

    n/a
    		 45,711

    FTD / Avg. Volume

    n/a
    		 9.5%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -1.5 and the forward PE ratio is null. aTyr Pharma's PEG ratio is 0.04.

    PE Ratio

    n/a
    		 -1.5

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 214.12

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.83

    P/FCF Ratio

    n/a
    		 -2.02

    PEG Ratio

    n/a
    		 0.04
    Financial Ratio History

    Enterprise Valuation

    aTyr Pharma has an Enterprise Value (EV) of 68.14M.

    EV / Sales

    n/a
    		 193.02

    EV / EBITDA

    n/a
    		 -1.31

    EV / EBIT

    n/a
    		 -2.05

    EV / FCF

    n/a
    		 -1.82

    Financial Position

    The company has a current ratio of 6.27, with a Debt / Equity ratio of 0.17.

    Current Ratio

    n/a
    		 6.27

    Quick Ratio

    n/a
    		 11.03

    Debt / Equity

    n/a
    		 0.17

    Debt / EBITDA

    n/a
    		 -0.29

    Debt / FCF

    n/a
    		 -0.4

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is -55.58% and Return on Invested Capital is -51.92%.

    Return on Equity

    n/a
    		 -55.58%

    Return on Assets

    n/a
    		 -41.28%

    Return on Invested Capital

    n/a
    		 -51.92%

    Revenue Per Employee

    n/a
    		 $6,303.57

    Profits Per Employee

    n/a
    		 $-899,803.57

    Employee Count

    n/a
    		 56

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 -0.04

    Taxes

    Income Tax

    n/a
    		 -8K

    Effective Tax Rate

    n/a
    		 0.02%

    Stock Price Statistics

    The stock price has increased by 18.75% in the last 52 weeks. The beta is 1.19, so aTyr Pharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.19

    52-Week Price Change

    n/a
    		 18.75%

    50-Day Moving Average

    n/a
    		 1.73

    200-Day Moving Average

    n/a
    		 1.59

    Relative Strength Index (RSI)

    n/a
    		 39.57

    Average Volume (20 Days)

    n/a
    		 480,976

    Income Statement

    In the last 12 months, aTyr Pharma had revenue of 353K and earned -50.39M in profits. Earnings per share was -0.94.

    Revenue

    n/a
    		 353K

    Gross Profit

    n/a
    		 -2.39M

    Operating Income

    n/a
    		 -54.92M

    Net Income

    n/a
    		 -50.39M

    EBITDA

    n/a
    		 -52.18M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -0.94
    Full Income Statement

    Balance Sheet

    The company has 22.54M in cash and 15.1M in debt, giving a net cash position of 7.45M.

    Cash & Cash Equivalents

    n/a
    		 22.54M

    Total Debt

    n/a
    		 15.1M

    Net Cash

    n/a
    		 7.45M

    Retained Earnings

    n/a
    		 -468.02M

    Total Assets

    n/a
    		 113.25M

    Working Capital

    n/a
    		 80.94M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -33.22M and capital expenditures -4.21M, giving a free cash flow of -37.44M.

    Operating Cash Flow

    n/a
    		 -33.22M

    Capital Expenditures

    n/a
    		 -4.21M

    Free Cash Flow

    n/a
    		 -37.44M

    FCF Per Share

    n/a
    		 -0.7
    Full Cash Flow Statement

    Margins

    Gross margin is -676.49%, with operating and profit margins of -15557.79% and -14274.5%.

    Gross Margin

    n/a
    		 -676.49%

    Operating Margin

    n/a
    		 -15557.79%

    Pretax Margin

    n/a
    		 -14276.77%

    Profit Margin

    n/a
    		 -14274.5%

    EBITDA Margin

    n/a
    		 -14781.3%

    EBIT Margin

    n/a
    		 -15557.79%

    FCF Margin

    n/a
    		 -10605.1%

    Dividends & Yields

    LIFE does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -66.67%

    FCF Yield

    n/a
    		 -49.53%
    Dividend Details

    Analyst Forecast

    The average price target for LIFE is $35, which is 1742.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $35

    Price Target Difference

    n/a
    		 1742.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jul 1, 2019. It was a backward split with a ratio of 1:14.

    Last Split Date

    n/a
    		 Jul 1, 2019

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:14

    Scores

    Altman Z-Score

    n/a
    		 -4.1

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist